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Summary
Background: The goal of asthma management is to achieve disease control, deﬁned.
as the ability to lead a normal life with normal pulmonary function. However, many
epidemiological surveys have demonstrated that asthma control is unacceptable in the
majority of patients.
Objective: To evaluate asthma control in 624 adults with asthma in the Maghreb,
participating in the AIRMAG survey.
Methods: As part of a general population survey of asthma in the Maghreb conducted
by structured telephone interview, information was obtained on asthma control and
treatment. Control was determined with the Asthma Control Test (ACT) and using an
algorithm based on the GINA control guidelines.
Results: The mean ACT score was 16.6±4.6, corresponding to uncontrolled asthma. Asthma
was uncontrolled (ACT score 19) in 71.3% of subjects and optimally controlled (ACT
score = 25) in 3.7%. Using the GINA-based algorithm, asthma was uncontrolled in 50.9% and
controlled in 7.6%. Asthma control differed between countries, being best in Tunisia and
worst in Morocco (p = 0.004). Only 163 subjects (26.1%) were receiving a recommended
prophylactic treatment (inhaled corticosteroids alone or in association with long-acting
b-agonists). Other factors associated with asthma control were educational level, asthma
perceptions and frequency of physician consultations.
Conclusions: Asthma control is unacceptably poor in the Maghreb. This could be changed by
improved access to appropriate treatments, more proactive patient follow-up and better
patient education.
© 2009 Published by Elsevier Ltd.
Introduction
The goal of the management of asthma is to obtain and
maintain asthma control. Asthma control has been deﬁned
*Tel: +971 4 332 1070; fax: +971 4 332 3071.
E-mail address: abdelkader.a.el-hasnaoui@gsk.com
(A. El Hasnaoui).
as the ability of the patient to lead a normal life with
normal pulmonary function. The Global Initiative for Asthma
(GINA) has proposed six criteria for evaluating asthma
control, and includes the absence of daytime symptoms
(no more than twice a week), the absence of night-time
symptoms, no limitations in activities, no need for rescue
medication (no more than twice a week), normal lung
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function (measured as forced expiratory volume in one
second or peak expiratory ﬂow) and no exacerbations 1. This
information can most easily be collected from the patient,
and for this reason several Patient Reported Outcome
(PRO) questionnaires, inspired by the GINA criteria, have
been developed for assessing and quantifying asthma
control in patients. These can be used both in everyday
clinical practice for optimising asthma treatment, and
in epidemiological studies for assessing the extent to
which treatment goals are being met. These include the
Asthma Control Questionnaire (ACQ) 2, the Asthma Therapy
Assessment Questionnaire (ATAQ) 3, the Asthma Control
Scoring System (ACSS) 4 and the Asthma Control Test 5,6.
Strategies for achieving optimal asthma control include
reduction in exposure to environmental risk factors, assess-
ment of asthma severity, appropriate treatment according
to severity level, regular monitoring of symptoms and lung
function, with adjustment of treatment intensity if neces-
sary, and ﬁnally patient education and information 1. Treat-
ment is based on the use of short-acting beta-agonists to
manage exacerbations and the prophylactic use of inhaled
corticosteroids, used either in monotherapy or in combina-
tion with long acting beta agonists, at a dose appropriate
for the severity of the asthma, to prevent further exacerba-
tions. The use of such treatment regimens, associated with
appropriate monitoring, can allow the majority of people
with asthma to achieve satisfactory asthma control 7.
In spite of the existence of effective treatments and
the widespread diffusion of asthma management guidelines,
such as those developed by GINA, asthma control in
everyday clinical practice remains far from satisfactory. For
example, in the different Asthma Reality and Insights (AIR)
surveys, conducted in several regions of the world, less than
half of the respondents were achieving acceptable asthma
control 8. A number of barriers to reducing the burden of
asthma have been identiﬁed, including exposure to environ-
mental pollution and smoking, limited access to effective
treatment, suboptimal organisation of healthcare provision,
and inadequate patient information and education 9. In
particular, cost of treatment is a barrier to effective
treatment in many low- and middle-income countries 10.
We have recently performed a large epidemiological
study (AIRMAG) to determine the prevalence of asthma in
the Maghreb region of North Africa (Morocco, Algeria and
Tunisia), a part of the world in which information on asthma
and its management is very limited. The data collected are
reported in an accompanying article in this supplement 11.
The study also provided an opportunity to collect data
on asthma control and treatment in these countries at
the same time. The AIRMAG study used the same general
methodology as the previous AIR studies elsewhere in the
world. Asthma control was evaluated using the ACT 5, as
well as operationally using an algorithm based on the GINA
criteria for asthma control. Since the ACT has only been
validated for use in adults and adolescents, the analysis was
not performed for the paediatric subgroup of the AIRMAG
study. This article presents the data obtained on asthma
control in adults.
Methods
This was a cross-sectional epidemiological survey of asthma
conducted in a random sample of the general population of
Algeria, Morocco and Tunisia between January 2008 and May
2008. The methodology of the study has been described in
detail in an accompanying article in this supplement 11, to
which the reader is referred for more information. A brief
summary is provided hereunder.
Data collection
A sample of the general population in each of the three
participating countries was generated using a random
stratiﬁed sampling method based on randomly-generated
lists of telephone numbers. The target sample of the study
consisted of 10000 individuals in each country. The study
population was divided into an adult group (aged sixteen
and over) and a paediatric group (under sixteen years).
Households were contacted by ringing each number in
the list consecutively. Each number was dialled up to ten
times in case of non-response before bring considered a
contact failure. After ten calls, outcomes were categorised
as interview, formal refusal, not a valid number (out of
service, not a household, or no response after ten calls).
Telephone interviews were conducted by seventeen local
interviewers (seven for Tunisia, ﬁve for Morocco and ﬁve for
Algeria). Interviewees could choose the language in which
they preferred to respond. The CAPI (Computer Assisted
Personal Interview) method and CONVERSO® software
(developed by Conversoft® France) were used for the
interview. Respondents were ﬁrst asked if they were
willing to participate in a questionnaire about health in
general. If so, information was requested on the household
structure (number in family: members, gender and age).
The household member to answer the questionnaire was
then selected randomly by the CAPI. In the case of children,
the parent answered the questionnaire on their behalf.
Two screening questions were asked to identify subjects
fulﬁlling diagnostic criteria for asthma, relating to occur-
rence of asthma symptoms and use of asthma treatments
Subjects responding positively to either of the questions
were considered as having asthma for the purposes of this
study. During a second step, subjects who met these criteria
were then questioned in more detail to collect information
on the frequency and severity of symptoms, impact on
activities of everyday life, treatments, monitoring, asthma
control and severity, and knowledge about asthma.
Assessment of asthma control
Asthma control was assessed in two ways. Firstly, the
Asthma Control Test (ACT) 6,12 was administered. This is
a questionnaire containing ﬁve items (Table 1) which
can each be rated on a ﬁve point Likert scale. Since
the ACT has only been validated in patients aged over
twelve, information obtained with this questionnaire was
only exploited for subjects in the adult subpopulation.
The second assessment was based on the GINA criteria
for asthma control 1. Data relating to the GINA criteria
for asthma control (Table 2) were extracted from the
questionnaire and used to assign subjects to one of
three levels of control (controlled, partially controlled and
uncontrolled). However, since pulmonary function testing
was not performed systematically during the study, this
criterion was not taken into account in the assessment.
Severity was assessed using an adaptation of the GINA-
based severity score used in the previous AIR studies 8.
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Table 1. Asthma Control Test
1. During the past 4 weeks, how often did your asthma prevent you from getting as much done at work, school or home?
2. During the past 4 weeks, how often have you had shortness of breath?
3. During the past 4 weeks, how often did your asthma symptoms (wheezing, coughing, shortness of breath, chest tightness or pain) wake you up at night or
earlier than usual in the morning?
4. During the past 4 weeks, how often have you used your rescue inhaler (such as salbutamol, terbutaline)?
5. How would you rate your asthma control during the past 4 weeks?
Table 2. GINA-based algorithm for determining asthma control
GINA criterion AIRMAG item Controlled Partly controlled Uncontrolled
All criteria
fulﬁlled
Any one item present
in anyone week
3 or more items
present in any week
Daytime symptoms Daytime symptoms  Twice a week > Twice a week > Twice a week
Limitations of activities Reduction in normal physical activity None Any Any
Nocturnal symptoms/awakenings Night-time awakenings
Sleeping difﬁculties
< Once a week  Once a week  Once a week
Need for reliever/rescue treatment Use of bronchodilators  Twice/week > Twice a week > Twice a week
Lung function (PEF or FVE1) If respiratory function tested, results
available for past 12 mo
Normal < 80% predicted or
personal best
< 80% predicted or
personal best
Exacerbations Occurrence of a severe episode in past 12 mo
Hospitalisation in past 12 mo
Emergency department visit in past 12 mo
None  1 per year  1 per year
Table 3. Asthma severity classiﬁcation algorithm
Intermittent Persistent
Mild Moderate Severe
Frequency of daytime symptoms < Twice a week  Twice a week Every day Several times a day
Frequency of night-time symptoms < Twice a month  Twice a month  Twice a week Every night
Frequency of severe episodes in the past 12 months < Twice a week  Twice a week Every day Every day
Exercise-induced symptoms in the past 12 months a < Twice a week  Twice a week Every day Every day
Symptom frequency during a typical week a  Twice a week 3 6 times a week 7 20 times a week  21 times a week
a Data for these two items (in italics) were not collected in this study.
Brieﬂy, one of four clinical severity grades (intermittent
asthma, mild persistent asthma, moderate persistent
asthma and severe persistent asthma) was assigned to each
patient based on frequency of the asthma symptoms. The
original severity score, presented in Table 3, contains ﬁve
items. However, data on the two last items (exercise-
induced symptoms and symptom frequency during a typical
week) were not collected in the AIRMAG study. The overall
severity grade assigned corresponded to the most severe
grade reported for any individual item. Subjects reporting
severe episodes every day over the previous years were
systematically assigned to the ’severe persistent’ severity
grade.
Statistical analysis
Inter-group comparisons were performed with the c2
test or Fisher’s exact test for categorical variables and
Student’s t-test for continuous variables (corrected using
the Welch-Satterthwaite equation in case of heterogeneous
variance).
The variables reported on the questionnaire were
assessed for association with the level of asthma control.
In a ﬁrst step, each variable was evaluated independently
in a univariate analysis. In a next step, all variables
associated with the level of asthma control at a probability
level of 0.25 in one or other of the univariate analyses
were entered into a multiple logistic regression analysis in
which variables were retained in the model in a ascending
stepwise manner in order to determine those that were
independently associated with the level of asthma control
at a probability level of 0.05. The variables ﬁnally retained
were entered into a ﬁnal multivariate model to generate
odds ratios. The validity of the ﬁnal model was evaluated
using the Hosmer-Lemeshow goodness of ﬁt test and its
predictive value by estimating the area under the curve of
a response operating characteristics curve (ROC).
Two-sided tests were used throughout and a probability
level of p < 0.05 was considered signiﬁcant. All data were
controlled, validated and analysed centrally (Kappa Sante´,
Paris, France) using SAS software, version 9.1 (SAS Institute,
Cary, USA).
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Results
Study sample
Overall, 872 individuals fulﬁlling the screening criteria for
asthma participated in the study, of whom 624 (71.6%) were
adults (154 in Algeria, 236 in Morocco and 234 in Tunisia).
The mean age of the subjects was 40.4 years, with those
in Morocco being somewhat younger than those in Algeria
and Tunisia (Table 4). The gender ratio was 1.46 in favour of
women, with a similar distribution in all three countries.
Table 4. Sociodemographic characteristics of adult subjects with asthma
identiﬁed in the survey
Algeria
(N = 154)
Morocco
(N = 236)
Tunisia
(N = 234)
Age
Mean±SD
Median [Range]
40.3±17.1
39 [16 90]
36.5±16.8
32 [16 80]
44.3±20.3
42 [16 100]
Gender
Women
Men
88 (57.1%)
66 (42.9%)
142 (60.2%)
94 (39.8%)
140 (59.8%)
94 (40.2%)
Asthma severity
Asthma was most frequently found to be severe persistent
(n = 212; 34.5%). The lowest severity grade (intermittent)
was assigned to 144 subjects overall (23.5%). In Algeria and
Morocco, around twice as many subjects were assigned a
severity grade of severe persistent compared to a grade
of intermittent (Fig. 1). In contrast, in Tunisia, subjects
were more frequently classiﬁed as intermittent (30.2%) than
severe persistent (25.4%). This between-country difference
in severity classiﬁcation was signiﬁcant (p < 0.01; Fisher’s
exact test).
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Fig. 1. Asthma severity. Data are presented as the percentage of
respondents.
Asthma control
The mean ACT score for asthma control was 16.6±4.6,
corresponding to uncontrolled asthma (Table 5). Indeed,
71.3% of subjects presented an ACT score 19, the cut-
off point for uncontrolled asthma. Only 22 subjects (3.7%)
scored 25 (optimally controlled asthma). Mean ACT scores
differed signiﬁcantly ( p = 0.004; ANOVA), being highest in
Tunisia and lowest in Morocco.
Table 5. Asthma control determined with the Asthma Control Test (ACT)
Algeria
(N = 154)
Morocco
(N = 236)
Tunisia
(N = 234)
ACT Score
Mean±SD
Median [Range]
16.7±4.4
17 [7 25]
15.8±4.8
16 [5 25]
17.3±4.6
17 [6 25]
Optimally controlled patient
(score = 25)
9 (6.4%) 4 (1.9%) 9 (3.9%)
Partially controlled patient
(score between 20 and 24)
31 (22%) 49 (22.8%) 67 (28.9%)
Patient not controlled
(score lower than 20)
101 (71.6%) 162 (75.3%) 156 (67.2%)
Table 6. Asthma control determined using an algorithm based on
the GINA criteria a
Asthma control level Algeria
(N = 154)
Morocco
(N = 236)
Tunisia
(N = 234)
Controlled 15 (10.6%) 9 (4.2%) 21 (9.1%)
Partially controlled 51 (35.9%) 85 (39.5%) 108 (46.5%)
Uncontrolled 76 (53.5%) 121 (56.3%) 103 (44.4%)
Missing data 12 21 2
a Data represent the number (%) of individuals with asthma in each control
category. If any criterion was not determined, the asthma control was
not attributed and the individual was classiﬁed as missing data.
Asthma control was also determined using the algorithm
based on the GINA criteria. According to this method, 7.6%
of subjects were considered to be controlled and 50.9% to
be uncontrolled (Table 6). The proportion of subjects with
uncontrolled asthma was lowest in Tunisia and the propor-
tion of those with controlled asthma lowest in Morocco.
This inter-country difference was signiﬁcant ( p = 0.02; c2
test). Control estimated using the GINA-based algorithm
was better than when assessed using the ACT (Fig. 2).
Fig. 2. Proportion of subjects assigned to three different control categories
using either the ACT criteria (left-hand member of each pair of histograms)
or the GINA-based algorithm (right hand member of each pair).
Treatment
Overall, 354 subjects (56.7%) were using short-acting
b-agonists for symptomatic relief of asthma symptoms.
This proportion was somewhat higher in Morocco (66.9%)
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Table 7. Treatments for asthma a
Algeria
(N = 154)
Morocco
(N = 236)
Tunisia
(N = 234)
Short-acting b-agonists 76 (49.4%) 158 (66.9%) 120 (51.3%)
Long-acting b-agonists +
corticosteroids
15 (9.7%) 28 (11.9%) 29 (12.4%)
Inhaled corticosteroids only 16 (10.4%) 54 (22.9%) 21 (9.0%)
Oral corticosteroids 27 (17.5%) 59 (25.0%) 20 (8.5%)
Oral antihistamines 14 (9.1%) 43 (18.2%) 11 (4.7%)
Other treatments 42 (27.3%) 89 (37.7%) 105 (44.9%)
a Multiple responses were possible.
compared to Algeria and Tunisia (Table 7). Inhaled cortico-
steroids alone or in association with long-acting b-agonists,
which are the prophylactic treatments recommended by
GINA, were used by 163 subjects (26.1%), more frequently
in Morocco. Oral steroids were used by 17% of subjects
overall, less often in Tunisia (8.5%) than in Algeria (17.5%)
and Morocco (25%).
Factors associated with asthma control
Univariate analysis identiﬁed a number of variables featured
in the questionnaire as being associated with asthma
control. Eleven of these were associated with control at
a probability threshold <0.05 and an additional twelve
variables at a probability level of 0.25, which was
the threshold required for entry into the multivariate
analysis. These variables are listed in Table 8. The three
variables with the strongest association with asthma control
(p < 0.001) were the educational level of the principal
breadwinner in the household, the perception of the
respondent that asthma is a psychological problem and the
frequency of consultation for asthma.
All variables retained were entered into a stepwise
multivariate logistic regression analysis which retained ﬁve
factors that were independently associated with asthma
control. These were country, the educational level of the
principal breadwinner in the household, the perceptions
of the respondent that a normal life is possible with
asthma and that asthma is a psychological problem, and
frequency of consultation for asthma. The probability of
achieving partial or optimal asthma control was higher
for respondents in Tunisia or Algeria compared with those
in Morocco, in households in which the breadwinner had
stopped schooling after elementary school or, alternatively,
had a university education, for respondents who considered
that it was possible to live a normal life with asthma and
who did not consider asthma to be a psychological problem,
and for respondents who had less frequently consulted a
physician for their asthma (Fig. 3).
The distribution of these variables between countries
and between control categories is presented in Table 9.
For approximately one third of subjects, the principal
breadwinner had received higher education, for a third
secondary education only and for the remaining third
primary education or no formal schooling. Overall, 71.3%
of patients completely or quite agreed that it was possible
to live a normal life with asthma and 64.5% completely
Table 8. Variables associated with asthma control identiﬁed in univariate analysis a
Variable p
Respondent consults because of severe asthma attacks 0.24
Age 0.23
Respondent considers that physician takes patient’s point of view of patient into consideration 0.21
Gender 0.18
Respondent aware of treatment guidelines 0.18
Country 0.17
Respondent aware of treatments for symptom relief 0.17
Respondent considers asthma as a fatal disease 0.13
Respondent considers freedom from symptoms as a reason for non-adherence 0.13
Respondent considers that effective treatment exists 0.07
Respondent regularly uses a ﬂow-meter in physician consultations 0.05
Respondent aware of treatments for symptom prevention 0.05
Respondent considers that a normal life is possible with asthma 0.02
Respondent resigned to living with asthma 0.01
Respondent considers that asthma gets worse with age 0.01
Respondent considers that the physician knows about asthma 0.01
Respondent considers that asthma restricts life-style 0.005
Profession of principal breadwinner in household 0.004
Respondent aware of peak ﬂow meter 0.004
Respondent considers that all treatments are equivalent 0.003
Educational level of principal breadwinner in household <0.001
Respondent considers that asthma is a psychological problem <0.001
Frequency of consultation for asthma <0.001
a All variables identiﬁed below a probability threshold of 0.25 are listed, and those below a threshold of 0.05
are indicated in boldface type.
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Visits to a physician for asthma: less once a year
Visits to a physician for asthma: 1-2 times a year
Visits to a physician for asthma: 3-11 times a year
Disagree that asthma is a psychological problem
Agree that a normal life is possible with asthma
University degree
Higher (non-university)
Primary and secondary
Tunisia
Algeria
Worse control vs re
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(Ref. Disagree)
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(Ref. No formal schooling)
(Ref.At least once a month)
(Ref. Morocco)
Better control vs referenceference
Fig. 3. Variables associated with asthma control identiﬁed by multiple logistic regression analysis. distribution of response modalities. Data are presented
as a Forest diagram showing odds ratios with their 95% conﬁdence intervals.
Table 9. Variables associated with asthma control identiﬁed in multivariate analysis ( p < 0.05) by country
Uncontrolled asthma
Algeria
(N = 101)
Morocco
(N = 162)
Tunisia
(N = 156)
Controlled asthma
Algeria
(N = 40)
Morocco
(N = 53)
Tunisia
(N = 76)
Educational level of breadwinner
No formal schooling
Primary/secondary
Higher (non-university)
University degree
32 (33.3%)
36 (37.5%)
13 (13.5%)
15 (15.6%)
20 (12.7%)
82 (51.9%)
30 (19%)
26 (16.5%)
31 (20%)
94 (60.7%)
19 (12.3%)
11 (7.1%)
5 (12.5%)
16 (40%)
7 (17.5%)
12 (30%)
0 (0%)
27 (51.9%)
11 (21.2%)
14 (26.9%)
7 (9.9%)
41 (57.8%)
16 (22.5%)
7 (9.9%)
Normal life is possible with asthma
Agree (totally or partially)
Disagree (totally or partially)
Do not know
81 (81%)
14 (14%)
5 (5%)
113 (70.2%)
46 (28.6%)
2 (1.2%)
89 (57.8%)
58 (37.7%)
7 (4.6%)
34 (85%)
5 (12.5%)
1 (2.5%)
43 (81.1%)
9 (17%)
1 (1.9%)
58 (76.3%)
16 (21.1%)
2 (2.6%)
Asthma is a psychological problem
Agree (totally or partially)
Disagree (totally or partially)
Do not know
78 (78%)
16 (16%)
6 (6%)
106 (65.4%)
51 (31.5%)
5 (3.1%)
105 (67.7%)
45 (29%)
5 (3.2%)
30 (75%)
9 (22.5%)
1 (2.5%)
19 (36.5%)
32 (61.5%)
1 (1.9%)
41 (54.7%)
34 (45.3%)
0 (0%)
Frequency of physician consultation
At least once a month
3 11 times a year
Once or twice a year
Less than once a year
42 (45.7%)
36 (39.1%)
9 (9.8%)
5 (5.4%)
26 (17.2%)
53 (35.1%)
43 (28.5%)
29 (19.2%)
29 (19.2%)
67 (44.4%)
41 (27.2%)
14 (9.3%)
10 (27.8%)
17 (47.2%)
6 (16.7%)
3 (8.3%)
2 (3.9%)
9 (17.7%)
28 (54.9%)
12 (23.5%)
4 (5.4%)
26 (35.1%)
32 (43.2%)
12 (16.2%)
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or quite agreed that asthma was a psychological problem.
Regarding consultation frequency, 55.9% of subjects had
consulted a physician for asthma between one and six times
a year. In the majority of cases (63.9%), consultation was
prompted by recurrence of asthma symptoms rather than
being programmed follow-up visits.
From the odds ratios derived from the logistic regression
analysis, it was possible to generate a mathematical model
to estimate the probability of achieving asthma control from
the values of the ﬁve variables retained:
Logit(p) = 3.98
+ (0.99[Country: Algeria] + 0.6[Country: Tunisia])
+ (0.76[EL: primary secondary]
+ 0.97[EL: other higher]
+ 1.29[EL: university])
+ (0.67[PNL: agree] + 0.73[PNL: no opinion])
+ (0.91[PP: agree] 0.42[PPP: no opinion])
+ (0.74[CF 3 11 times/year]
+ 1.58[CF 1 2 times/year]
+ 1.29[CF < once a year]),
where C = country, EL = educational level; PNL = perception
that asthma allows a normal life, PPP = perception that
asthma is a psychological problem and CF = consultation
frequency.
The sensitivity of the model for predicting asthma
control was 75% and its speciﬁcity 59%. Goodness of ﬁt
was estimated using the Hosmer and Lemleshow test and
found to be high (p = 0.65). Its discriminant properties
were evaluated by construction of a receiver operating
characteristics curve (Fig. 4). The area under the curve was
0.73, consistent with acceptable discriminant capacity.
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Fig. 4. Receiver operating characteristics curve of the model for predicting
asthma control.
Discussion
The principal ﬁnding of this study was that asthma
control in the Maghreb countries of North Africa is poor.
Indeed, using the ACT questionnaire, 71.3% of respondents
were classiﬁed as having uncontrolled asthma and only
22 respondents (3.7%) were considered to be optimally
controlled. Using the GINA-based algorithm, the ﬁndings
were generally similar, although control was estimated
to be somewhat better. Notably, 50.9% of subjects were
classiﬁed as uncontrolled and 45 subjects as controlled.
However, this operational algorithm is likely to overestimate
asthma control, since pulmonary function, which was not
tested in this study, was excluded from the algorithm.
It has been suggested previously that asthma control is
likely to be over-estimated if evaluated from symptoms
alone 13. In addition, it should be noted that the ACT
was developed and optimised as a PRO measure, whereas
the GINA-based algorithm is an operational measure of
control based on clinical features, whose reliability as a
PRO is not known. For this reason, the ACT is a more
suitable instrument for assessing control when directly
asking the patient.
The poor level of control is likely to result principally
from the relatively low proportion of respondents using
a recommended prophylactic treatment. Only around one
quarter of respondents reported using inhaled cortico-
steroids. Nonetheless, inhaled corticosteroids would not
be appropriate for a proportion of patients in this study
whose untreated asthma was intermittent. Unfortunately,
it is not possible to estimate the size of this patient group
in such a general population survey since patients with
naturally intermittent asthma without treatment cannot
be distinguished from treated patients with naturally
persistent asthma who are well controlled by their
treatment. The level of control achieved is thus inﬂuenced
not only by the underlying severity of disease, but also by
the appropriateness of care and treatment.
It has been emphasised previously that limited access
to these treatments represents a barrier to their more
widespread use in low- to middle-income countries 10, and
this is likely to be the case as well in the Maghreb.
Several factors potentially inﬂuence access to treatment
in these countries, and may contribute to some of the
inter-country differences observed. For example, Algeria
has put into place a socialised medicine model since
independence. In this country, physician consultation and
access to community hospitals and clinics are generally
reimbursed, chronic diseases are recognised and their
treatment funded by the state, and physician density is
high (1 for 900 inhabitants). Tunisia developed the ﬁrst
national health insurance scheme in the Maghreb and has
developed a speciﬁc care network devoted to asthma as
well as hospital centres of excellence. Morocco introduced
their public health insurance system more recently and
this is currently in an expansion phase. However, certain
sectors of the population still remain without easy or cheap
access to care, and physician density remains low (1 for
3700 inhabitants).
Another factor inﬂuencing the rather low use of inhaled
corticosteroids is limited awareness of the disease and
treatment by patients (and potentially of certain treating
physicians). In our sample, only 18% of subjects were
aware that asthma was caused by inﬂammation of the
airways and only 1% knew that corticosteroids could reduce
inﬂammation.
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Although the cost of such treatments is clearly an
issue in countries with limited resources, the cost of not
using appropriate prophylaxis is also high. Hospitalisation,
emergency department and unscheduled clinic visits and
use of rescue medication contribute to medical expenditure
for managing exacerbations, which make up around half
of the total costs of the management of asthma 14. In
the AIRMAG population, around one quarter of subjects
were making visits to the emergency department due to
a severe asthma attack 11, many of which could be avoided
if asthma was adequately controlled by the appropriate use
of prophylactic medication.
A number of factors were found to be independently
associated with poor asthma control. Asthma control was
worse in Morocco than in the other two Maghreb countries,
and this may relate to a less developed national health
service here than in the other two countries. Asthma
control was also associated with the frequency of physician
consultation, with subjects who consulted less frequently
for asthma being better controlled. This reﬂects the fact
that the majority of respondents only consulted their
physician in case of exacerbations, with only one-third of
them reporting programmed follow-up consultations. This
is clearly an area in which improvements can be made. The
GINA guidelines 1 explicitly recommend regular monitoring
for all patients with asthma, to assess symptom control, to
evaluate lung function and to adjust treatment if necessary.
In the AIRMAG population, only 17% of respondents reported
having undergone lung function testing and only 32%
had used a ﬂow meter. Physician education in order
to ensure that all patients are proposed regular follow
up with lung function testing could thus be a simple
and effective measure to improve asthma control in the
Maghreb countries.
Two items relating to perceptions of asthma were also
associated with better asthma control in the multivariate
logistic analysis. These were that the respondent considered
asthma to be compatible with a normal life and that the
correspondent did not consider asthma to be a psychological
problem. The former item is to some extent a tautology, in
that asthma control is deﬁned as allowing the patient to live
a normal life. However, it may also reﬂect expectations,
with respondents who believe that asthma should not
prevent them from living a normal life being more likely
to take an active role in the management of their asthma.
The item related to asthma being a psychological problem
reﬂects poor patient information, and may well result
in poor adherence to treatment and lack of motivation
for participating in asthma management. In this respect,
physicians should be encouraged to spend time talking to
patients and explaining that asthma is a treatable condition
caused by inﬂammation of the airways leading to episodic
attacks. In this way, the rather high proportion of subjects
(63%) who consider asthma to be a psychological problem
may be reduced.
Finally, asthma control was also related to the educa-
tional level of the household breadwinner, being better in
more highly educated households. This association likely
reﬂects, on the one hand, greater awareness of asthma, its
treatment and its consequences and, on the other, better
access to care and treatment through a higher income
level. Asthma control was better in all educational level
groups compared to uneducated subjects. A certain level of
literacy is required for effective communication with the
physician and assimilating prescribing recommendations for
treatment. In this respect, the illiteracy rate in the Maghreb
is between 15% and 25%.
Asthma control may also be improved by reduction
in exposure to environmental risk factors. Notably, a
signiﬁcant number of respondents (43, half of whom were
in Tunisia) were active smokers and between one-third
and one-half were exposed to another member of the
household who smoked. The importance of eliminating
active and passive exposure to tobacco smoke cannot be
over-emphasised and the relationship between smoking and
asthma deserves to be explicitly brought out in public anti-
smoking campaigns as well as in the dialogue between the
physician and the patient with asthma.
In conclusion, asthma control in the Maghreb countries of
North Africa is poor. Simple physician education measures
related to patient follow-up and patient information may
be of use in improving this situation, and barriers to access
to appropriate treatments need to be lowered.
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